Lemtrada 12Mg Vial Of 1.2Ml Injection
1.2ml Injection in VialMRP ₹665000.00
₹598050.00
10% OFF
Made by
SANOFI
Dosage
INJECTION
Expiry
Product Summary
| Uses | Relapsing-remitting multiple sclerosis |
| Therapy | Drugs for multiple sclerosis, anti-neoplastic |
| Side effects | Headache, fever or chills, nausea and vomiting |
| Salt Content | Alemtuzumab(12.0 Mg) |
Assurance
available
Regulated
Medical Description
Lemtrada injection is used to treat relapsing-remitting forms of multiple sclerosis (MS) and contains alemtuzumab, a CD52-directed monoclonal antibody. It binds to CD52 on certain white blood cells and causes their depletion, reducing the abnormal immune activity involved in MS.
Because Lemtrada injection significantly reduces certain blood cells and suppresses the immune system, it can increase the risk of serious or potentially fatal infections and other complications. Close medical monitoring and infection-prevention measures are required during and after treatment.
Lemtrada injection is administered as a slow intravenous infusion, by trained healthcare professionals. Premedication is given before each infusion to reduce infusion-related reactions, which may include fever, chills, low blood pressure, breathing difficulties, wheezing, or rash.
Lemtrada injection must be used exactly as prescribed and should not be started, stopped, or modified without medical advice. Serious risks include severe reductions in blood-cell counts, serious infusion reactions, and serious or potentially fatal infections.
Before treatment, tell your doctor if you have an active infection, immune-system disorder, heart condition, low blood pressure, or a previous serious reaction to alemtuzumab or other medicines. Also provide a complete list of all medicines, supplements, vitamins, and herbal products you take.
Women who could become pregnant should use effective contraception during treatment and for the recommended period after the last treatment course. Because regular blood monitoring is required during treatment and for an extended period afterward, Lemtrada injection should only be administered under appropriate medical supervision.
Uses
Contraindications
- If you are allergic to alemtuzumab or any component of Lemtrada injection.
- If you have an active infection.
- If you have HIV infection.
Side effects
- Headache
- Fever or chills
- Nausea and vomiting
- Rash or itching
- Tiredness or weakness
- Back pain or joint pain
- Difficulty sleeping
- Mouth or throat pain
- Cough or shortness of breath
- Low white blood cell counts (may increase infection risk)
- Severe infections (e.g., pneumonia, urinary tract infections, viral reactivation)
- Autoimmune disorders, including immune thrombocytopenia and kidney disorders
- Infusion-related reactions
- Thyroid disorders
- Serious blood count abnormalities
- Liver problems
- Bleeding or bruising easily
- Neurological issues
- Risk of certain cancers
Precautions and Warnings
Pregnancy
Driving
Alcohol
Breast Feeding
Other General Warnings
- Patients should not receive live viral vaccines while on or recently after Lemtrada injection treatment.
- Patients should immediately report any signs of infection (such as fever), unusual bleeding, bruising, or other severe symptoms to their doctor
- Regular monitoring is essential, including blood counts, kidney function and urine testing, and thyroid function tests during treatment and for an extended period after treatment.
- Seek immediate medical attention for severe headache, weakness, speech or vision changes, chest pain, difficulty breathing, severe bleeding, or symptoms of a serious infection.
Directions for Use
- Lemtrada injection is prepared and given by a doctor or nurse; it is not for self-administration at home. Do not self-inject. Follow any aftercare instructions given by the doctor/nurse.
- The medicine is given as an IV infusion (slow drip into a vein).
- Premedication with corticosteroids is given before each treatment course, and additional medicines may be given when required to reduce infusion-related reactions.
Storage and disposal
- Store Lemtrada injection vials in a refrigerator at 2°C to 8°C (36°F to 46°F)
- Do not freeze; if accidentally frozen, thaw in the refrigerator (2°C to 8°C) before use.
- Protect the vials from direct sunlight
- Any unused medicine remaining in the vial after a dose is withdrawn should be discarded and never reused.
- Keep out of reach of children and pets.
Quick Tips
- Take only under medical supervision: Alemtuzumab must be given in a hospital or clinic due to the risk of serious immune-related side effects.
- Attend all follow-up tests: Regular blood and urine tests (up to 4 years) are essential to monitor for delayed side effects.
- Use reliable contraception: Women should avoid pregnancy during treatment and for at least 4 months after the last dose.
- Report signs of infection: Contact your doctor if you develop fever, cough, or sore throat, as the immune system may be weakened.
- Avoid live vaccines: Do not take live or weakened vaccines unless advised by your doctor during and after treatment.
Dosage
Missed a Dose
Overdose
How does this medicine work?
Interactions
Interactions with other medicines
- Inform your doctor about all prescription medicines, over-the-counter medicines, supplements, and herbal products you take.
- Tell your doctor before receiving any vaccination. Live vaccines should generally be avoided during treatment and until your immune system has recovered sufficiently.
- Other medicines that affect the immune system may increase the risk of infections or other adverse effects.
Frequently Asked Questions (FAQs)
References:
- Genzyme Corporation. CAMPATH (alemtuzumab) injection, for intravenous use: full prescribing information [Internet]. Cambridge (MA): Genzyme Corporation; 2019 Nov [cited 2 026 Aug 7].
- OncoLink, University of Pennsylvania. Alemtuzumab (Campath®) [Internet]. Philadelphia (PA): OncoLink; 2025 Aug 8 [cited 2026 Aug 7].
- Central Drugs Standard Control Organisation (CDSCO). Drugs@CDSCO [Internet]. New Delhi: Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India; [cited 2026 Aug 10].
Articles
View All
Chronic Condition Articles
View All
Did you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:LEMTRADA
Vendor Details
Fulfillment Information: Lemtrada 12 MG Injection (1.2) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
